| Literature DB >> 21929870 |
Dongsun Park1, Seong Soo Joo, Tae Kyun Kim, Sun Hee Lee, Hyomin Kang, Hong Jun Lee, Inja Lim, Akinori Matsuo, Ikuo Tooyama, Yun-Bae Kim, Seung U Kim.
Abstract
Alzheimer disease (AD) is a progressive neurodegenerative disease, which is characterized by loss of memory and cognitive function. In AD patients dysfunction of the cholinergic system is the main cause of cognitive disorders, and decreased activity of choline acetyltransferase (ChAT), an enzyme responsible for acetylcholine (ACh) synthesis, is observed. In the present study we investigated if brain transplantation of human neural stem cells (NSCs) genetically modified to encode ChAT gene improves cognitive function of kainic acid (KA)-induced learning deficit rats. Intrahippocampal injection of KA to hippocampal CA3 region caused severe neuronal loss, resulting in profound learning and memory deficit. F3.ChAT human NSCs transplanted intracerebroventricularly improved fully the learning and memory function of KA-induced learning deficit animals, in parallel with the elevation of ACh levels in cerebrospinal fluid. F3.ChAT human NSCs migrated to the KA-induced injury site (CA3) and differentiated into neurons and astrocytes. The present study demonstrates that human NSCs expressing ChAT have lesion-tropic property and improve cognitive function of learning deficit model rats with hippocampal injury by increasing ACh level.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21929870 DOI: 10.3727/096368911X586765
Source DB: PubMed Journal: Cell Transplant ISSN: 0963-6897 Impact factor: 4.064